» Articles » PMID: 2456985

Functional T Cell Recognition of Synthetic Peptides Corresponding to Continuous Antibody Epitopes of Herpes Simplex Virus Type 1 Glycoprotein D

Overview
Journal Immunobiology
Publisher Elsevier
Date 1988 May 1
PMID 2456985
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Four synthetic peptides which correspond to continuous antibody epitopes of herpes simplex virus (HSV) type 1 glycoprotein D (gD) within amino acid residues 1-23 (8-23), 268-287 and 340-356 were evaluated for in vitro stimulating activity on HSV-primed murine T lymphocytes. All peptides stimulated lymphoproliferative responses and interleukin 2 (IL2) production from draining lymph node (LN) cell populations taken 5 days after footpad immunization with live HSV. Similar responses were elicited from splenic memory T cells only if these T cells were restimulated with HSV in vitro and rested prior to peptide stimulation. Furthermore, peptide stimulated memory T cell populations released soluble factor(s) into the culture supernates which modulated the induced lymphoproliferative and cytotoxic T lymphocyte (CTL) activities of HSV-stimulated, HSV-immune splenocytes (indicator cultures). Memory T cell supernates suppressed lymphoproliferation of indicator cultures, while CTL activity of indicator cultures was either enhanced or suppressed, depending on the peptide and concentration. In contrast, supernates generated by peptide stimulation of draining LN cells had no effect on CTL activity of indicator cultures. However, the lymphoproliferative responses were augmented with three of the four peptides at the highest concentration of peptides tested. Our experiments indicate T helper (Th) and T suppressor (Ts) lymphocyte recognition of four synthetic peptides which encompass continuous antibody epitopes of HSV gD. Immunization with one of these peptides (1-23) induces virus neutralizing antibodies and protection against lethal viral challenge. Th lymphocyte recognition of this peptide in particular, together with its observed function in the induction of protection against HSV infection, indicates that this peptide is a promising candidate as a synthetic vaccine against HSV infection.

Citing Articles

A Herpes Simplex Virus Type 2 Deleted for Glycoprotein D Enables Dendritic Cells to Activate CD4 and CD8 T Cells.

Retamal-Diaz A, Kalergis A, Bueno S, Gonzalez P Front Immunol. 2017; 8:904.

PMID: 28848543 PMC: 5553038. DOI: 10.3389/fimmu.2017.00904.


Liposomal gD ectodomain (gD1-306) vaccine protects against HSV2 genital or rectal infection of female and male mice.

Olson K, Macias P, Hutton S, Ernst W, Fujii G, Adler-Moore J Vaccine. 2009; 28(2):548-60.

PMID: 19835825 PMC: 2824512. DOI: 10.1016/j.vaccine.2009.09.120.


Fine mapping of antigenic site II of herpes simplex virus glycoprotein D.

Isola V, Eisenberg R, Siebert G, Heilman C, Wilcox W, Cohen G J Virol. 1989; 63(5):2325-34.

PMID: 2467994 PMC: 250651. DOI: 10.1128/JVI.63.5.2325-2334.1989.


Influence of peptide acylation, liposome incorporation, and synthetic immunomodulators on the immunogenicity of a 1-23 peptide of glycoprotein D of herpes simplex virus: implications for subunit vaccines.

Brynestad K, Babbit B, Huang L, Rouse B J Virol. 1990; 64(2):680-5.

PMID: 2153234 PMC: 249160. DOI: 10.1128/JVI.64.2.680-685.1990.